Presents recent advances in drug repurposing and computational approaches for the discovery and development of drugs for certain difficult-to-treat and life-threatening diseases, providing information on computational techniques, tools, and databases for identifying the uses of existing drug candidates on different emerging diseases.
Presents recent advances in drug repurposing and computational approaches for the discovery and development of drugs for certain difficult-to-treat and life-threatening diseases, providing information on computational techniques, tools, and databases for identifying the uses of existing drug candidates on different emerging diseases.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Mithun Rudrapal, PhD, FIC, FICS, CChem (India), is Associate Professor at the Department of Pharmaceutical Sciences, School of Biotechnology & Pharmaceutical Sciences, Vignan's Foundation for Science, Technology and Research (Deemed to be University), Guntur, India. Dr. Rudrapal has been actively engaged in teaching and research the field of pharmaceutical and allied sciences for more than 12 years. He has over 100 publications in peer-reviewed international journals to his credit and has filed a number Indian and international patents. In addition, Dr. Rudrapal is the author of dozen published or forthcoming books. Dr. Rudrapal works in the areas of medicinal chemistry, cadd, drug repurposing, phytochemistry, herbal drugs, and nanophytotherapeutics.
Inhaltsangabe
1. Drug Repurposing in Future Drug Discovery and Development 2. Approaches, Strategies, and Advances in Computational Drug Discovery and Drug Repurposing 3. Drug Repurposing and Computational Drug Discovery for Viral Infections and Corona Virus Disease 2019 (COVID-19) 4. Drug Repurposing and Computational Drug Discovery for Parasitic Diseases and Neglected Tropical Diseases (NTDs) 5. Drug Repurposing and Computational Drug Discovery for Malignant Diseases 6. Drug Repurposing and Computational Drug Discovery for Inflammatory Diseases 7. Drug Repurposing and Computational Drug Discovery for Cardiovascular Disorders 8. Drug Repurposing and Computational Drug Discovery for Diabetes 9. Drug Repurposing and Computational Drug Discovery for Aging and Neurological Disorders 10. Challenges and Regulatory Issues in Drug Repurposing and Computational Drug Discovery
1. Drug Repurposing in Future Drug Discovery and Development 2. Approaches, Strategies, and Advances in Computational Drug Discovery and Drug Repurposing 3. Drug Repurposing and Computational Drug Discovery for Viral Infections and Corona Virus Disease 2019 (COVID-19) 4. Drug Repurposing and Computational Drug Discovery for Parasitic Diseases and Neglected Tropical Diseases (NTDs) 5. Drug Repurposing and Computational Drug Discovery for Malignant Diseases 6. Drug Repurposing and Computational Drug Discovery for Inflammatory Diseases 7. Drug Repurposing and Computational Drug Discovery for Cardiovascular Disorders 8. Drug Repurposing and Computational Drug Discovery for Diabetes 9. Drug Repurposing and Computational Drug Discovery for Aging and Neurological Disorders 10. Challenges and Regulatory Issues in Drug Repurposing and Computational Drug Discovery
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/neu
